全球外科黏合劑市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球外科黏合劑市場預計將從2025年的34.5億美元成長至2034年的68.4億美元，2026年至2034年的複合年成長率（CAGR）為7.91%。該市場正經歷顯著成長，主要受醫療手術中對先進傷口縫合解決方案需求不斷成長的推動。由於其使用方便且能縮短癒合時間，外科黏合劑被廣泛用作縫合線和縫合釘的替代品。手術數量的增加以及微創手術的日益普及是推動市場擴張的主要因素。

關鍵促進因素包括黏合劑技術的進步以及對患者安全和舒適度的日益關注。醫療專業人員正在採用外科黏合劑來改善手術效果並減少併發症。不斷擴大的醫療基礎設施和不斷成長的醫療支出也推動了市場成長。此外，可生物分解和生物相容性黏合劑的創新正在提升產品性能。

外科黏合劑市場前景依然樂觀，持續的研究有望催生出更有效、用途更廣泛的產品。先進生物材料的整合將進一步提升產品的安全性和功能性。在新興市場，醫療保健服務的改善預計將創造新的成長機會。總體而言，在醫療技術進步的推動下，該市場有望穩定成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為深入了解競爭動態和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球外科黏合劑市場：依產品類型分類

• 市場分析、洞察與預測
• 天然成分（纖維蛋白、膠原蛋白、明膠）
• 合成與半合成（氰基丙烯酸酯、聚合物水凝膠、胺甲酸乙酯黏合劑）

第5章 全球外科黏合劑市場：依應用領域分類

• 市場分析、洞察與預測
• 心血管外科
• 整形外科手術
• 一般外科
• 整形手術
• 肺部手術
• 中樞神經系統手術
• 其他

第6章 全球外科黏合劑市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 其他

第7章 全球外科黏合劑市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • CSL Limited
  • Johnson & Johnson
  • Cohera MedicalInc
  • Vivostat
  • Sealantis Ltd
  • Ocular Therapeutix Inc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Sanofi
  • CryoLife Inc

The global surgical glue market size is expected to reach USD 6.84 Billion in 2034 from USD 3.45 Billion in 2025, growing at a CAGR of 7.91 during 2026-2034.This market is witnessing significant growth driven by increasing demand for advanced wound closure solutions in medical procedures. Surgical glue is widely used as an alternative to sutures and staples due to its ease of application and reduced healing time. The rising number of surgical procedures and growing preference for minimally invasive techniques are major factors contributing to market expansion.

Key drivers include advancements in adhesive technologies and increasing focus on patient safety and comfort. Healthcare providers are adopting surgical glue to improve surgical outcomes and reduce complications. The expansion of healthcare infrastructure and increasing healthcare expenditure are also supporting market growth. Additionally, innovations in biodegradable and biocompatible adhesives are enhancing product performance.

The future outlook for the surgical glue market remains positive, with ongoing research expected to introduce more effective and versatile products. The integration of advanced biomaterials will further improve safety and functionality. Emerging markets are expected to provide new growth opportunities due to improving healthcare access. Overall, the market is poised for steady growth driven by advancements in medical technology.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Natural (Fibrin, Collagen, Gelatin)
• Synthetic and Semi Synthetic (Cyanoacrylate, Polymeric Hydrogel, Urethane-based Adhesive)

By Application

• Cardiovascular Surgery
• Orthopedic Surgery
• General Surgery
• Cosmetic Surgery
• Pulmonary Surgery
• Central Nervous System Surgery
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• CSL Limited, Johnson & Johnson, Cohera Medical, Inc., Vivostat, Sealantis Ltd., Ocular Therapeutix Inc., B. Braun Melsungen AG, Baxter International Inc., Sanofi, CryoLife Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SURGICAL GLUE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Natural (Fibrin, Collagen, Gelatin) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Synthetic and Semi Synthetic (Cyanoacrylate, Polymeric Hydrogel, Urethane-based Adhesive) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SURGICAL GLUE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cardiovascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Orthopedic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. General Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Cosmetic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Pulmonary Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Central Nervous System Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SURGICAL GLUE MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SURGICAL GLUE MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SURGICAL GLUE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 CSL Limited
  • 9.2.2 Johnson & Johnson
  • 9.2.3 Cohera MedicalInc
  • 9.2.4 Vivostat
  • 9.2.5 Sealantis Ltd
  • 9.2.6 Ocular Therapeutix Inc
  • 9.2.7 B. Braun Melsungen AG
  • 9.2.8 Baxter International Inc
  • 9.2.9 Sanofi
  • 9.2.10 CryoLife Inc